Selskabet har opnået følgende resultat for de tre første kvartaler 2024:
- Dimensional Fund Advisors Ltd. : Form 8.3 – NEWRIVER REIT PLC – Ordinary Shares - December 9, 2024
- Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers - December 9, 2024
- Offer Update – Extension of Early Bird Discount Period - December 9, 2024